Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001179110-20-004008

Options or other derivatives

  • Director acquired 4,496 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
JEFFS ROGER Director 2020-03-17 Grant or award · Stock Option (Right to Buy) +4,496 4,496 D
Loading xslF345X03/edgar.xml…